However, one may also argue that RS has a Type IV tumor microenvironment, as the PD-L1 expression is primarily on histiocytes and dendritic cells instead of tumor B cells; therefore, immunotherapy strategies in addition to PD1 blockade may be necessary. This evidence concerns the gene CD274 and neoplasm.